Drug Index


Synonym :


Mechanism :

Norepinephrine is a sympathomimetic amine which differs from epinephrine by the absence of a methyl group on the nitrogen atom. Norepinephrine functions as a peripheral vasoconstrictor (alpha-adrenergic action) and as an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action).

Indication :

  • Cardiac surgery - post-op low cardiac output
  • Acute hypotension
  • Shock
  • Cardiac arrest

Contraindications :

Norepinephrine should not be given to patients who are hypotensive from blood volume deficits except as an emergency measure. If norepinephrine is continuously administered to maintain blood pressure in the absence of blood volume replacement, the following may occur: severe peripheral and visceral vasoconstriction, decreased renal perfusion and urine output, poor systemic blood flow, tissue hypoxia, and lactate acidosis.

Norepinephrine should also not be given to patients with mesenteric or peripheral vascular thrombosis unless it is necessary as a life-saving procedure.

Cyclopropane and halothane anesthetics increase cardiac autonomic irritability, hence the use of Norepinephrine during cyclopropane and halothane anesthesia is generally considered contraindicated.

Dosing :

IV infusion
0.05-0.1 mcg/kg/min (Max: 1-2 mcg/kg/min). Monitor ECG and hemodynamic parameters.

Adverse Effect :

Ischemic injury due to potent vasoconstrictor action and tissue hypoxia, bradycardia, probably as a reflex result of a rise in blood pressure, arrhythmias, anxiety, transient headache, confusion, headache, restlessness, nausea, vomiting, respiratory difficulty, extravasation necrosis at injection site, sweating, tremors, urinary retention.

Interaction :

Cyclopropane and Halothane Anesthetics: Increase cardiac automatic irritability and sensitize the myocardium to the action of intravenously administered epinephrine or norepinephrine, hence, the risk of producing ventricular tachycardia or fibrillation.
Monoamine Oxidase Inhibitors: Norepinephrine should be used with extreme caution in patients receiving (MAOI) or antidepressants of the triptyline or imipramine types, because severe, prolonged hypertension may result.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in normal renal function
HDNot dialysed. Dose as in normal renal function
HDF/High fluxUnknown dialysability. Dose as in normal renal function
CAV/VVHDNot dialysed. Dose as in normal renal function

Hepatic Dose :

No dosage adjustments are recommended.
11/01/2020 12:51:49 Noradrenaline
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0